<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Neural Development - Latest articles</title>
		<link>http://www.neuraldevelopment.com</link>
		<description>The latest articles from Neural Development (ISSN 1749-8104) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/24"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/23"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/22"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/21"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/20"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/19"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/18"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/17"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/16"/>			    
            
				    <rdf:li rdf:resource="http://www.neuraldevelopment.com/content/3/1/15"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/24">
            
            <title>A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction</title>
			<description>Background:
The skeletal neuromuscular junction is a useful model for elucidating mechanisms that regulate synaptogenesis. Developmentally important intercellular interactions at the neuromuscular junction are mediated by the synaptic portion of a basal lamina that completely ensheaths each muscle fiber. Basal laminas in general are composed of four main types of glycosylated proteins: laminins, collagens IV, heparan sulfate proteoglycans and nidogens (entactins). The portion of the muscle fiber basal lamina that passes between the motor nerve terminal and postsynaptic membrane has been shown to bear distinct isoforms of the first three of these. For laminins and collagens IV, the proteins are deposited by the muscle; a synaptic proteoglycan, z-agrin, is deposited by the nerve. In each case, the synaptic isoform plays key roles in organizing the neuromuscular junction. Here, we analyze the fourth family, composed of nidogen-1 and -2.
Results:
In adult muscle, nidogen-1 is present throughout muscle fiber basal lamina, while nidogen-2 is concentrated at synapses. Nidogen-2 is initially present throughout muscle basal lamina, but is lost from extrasynaptic regions during the first three postnatal weeks. Neuromuscular junctions in mutant mice lacking nidogen-2 appear normal at birth, but become topologically abnormal as they mature. Synaptic laminins, collagens IV and heparan sulfate proteoglycans persist in the absence of nidogen-2, suggesting the phenotype is not secondary to a general defect in the integrity of synaptic basal lamina. Further genetic studies suggest that synaptic localization of each of the four families of synaptic basal lamina components is independent of the other three.
Conclusions:
All four core components of the basal lamina have synaptically enriched isoforms. Together, they form a highly specialized synaptic cleft material. Individually, they play distinct roles in the formation, maturation and maintenance of the neuromuscular junction.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/24</link>
			
			 	<dc:creator>Michael A Fox, Matthew S Ho, Neil Smyth and Joshua R. Sanes</dc:creator>
			
			<dc:source>Neural Development 2008, 3:24</dc:source>
			<dc:date>2008-09-25</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-24</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>24</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/23">
            
            <title>A chemical-genetic strategy reveals distinct temporal requirements for SAD-1 kinase in neuronal polarization and synapse formation</title>
			<description>Background:
Neurons assemble into a functional network through a sequence of developmental processes including neuronal polarization and synapse formation. In Caenorhabditis elegans, the serine/threonine SAD-1 kinase is essential for proper neuronal polarity and synaptic organization. To determine if SAD-1 activity regulates the establishment or maintenance of these neuronal structures, we examined its temporal requirements using a chemical-genetic method that allows for selective and reversible inactivation of its kinase activity in vivo.
Results:
We generated a PP1 analog-sensitive variant of SAD-1. Through temporal inhibition of SAD-1 kinase activity we show that its activity is required for the establishment of both neuronal polarity and synaptic organization. However, while SAD-1 activity is needed strictly when neurons are polarizing, the temporal requirement for SAD-1 is less stringent in synaptic organization, which can also be re-established during maintenance.
Conclusion:
This study reports the first temporal analysis of a neural kinase activity using the chemical-genetic system. It reveals that neuronal polarity and synaptic organization have distinct temporal requirements for SAD-1.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/23</link>
			
			 	<dc:creator>Joanne SM Kim, Brendan N Lilley, Chao Zhang, Kevan M Shokat, Joshua R Sanes and Mei Zhen</dc:creator>
			
			<dc:source>Neural Development 2008, 3:23</dc:source>
			<dc:date>2008-09-22</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-23</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>23</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/22">
            
            <title>Expressing exogenous functional odorant receptors in cultured olfactory sensory neurons</title>
			<description>Background:
Olfactory discrimination depends on the large numbers of odorant receptor genes and differential ligand-receptor signaling among neurons expressing different receptors. In this study, we describe an in vitro system that enables the expression of exogenous odorant receptors in cultured olfactory sensory neurons. Olfactory sensory neurons in the culture express characteristic signaling molecules and, therefore, provide a system to study receptor function within its intrinsic cellular environment.
Results:
We demonstrate that cultured olfactory sensory neurons express endogenous odorant receptors. Lentiviral vector-mediated gene transfer enables successful ectopic expression of odorant receptors. We show that the ectopically expressed mouse I7 is functional in the cultured olfactory sensory neurons. When two different odorant receptors are ectopically expressed simultaneously, both receptor proteins co-localized in the same olfactory sensory neurons up to 10 days in vitro.
Conclusion:
This culture technique provided an efficient method to culture olfactory sensory neurons whose morphology, molecular characteristics and maturation progression resembled those observed in vivo. Using this system, regulation of odorant receptor expression and its ligand specificity can be studied in its intrinsic cellular environment.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/22</link>
			
			 	<dc:creator>Huaiyang Chen, Sepehr Dadsetan, Alla F Fomina and Qizhi Gong</dc:creator>
			
			<dc:source>Neural Development 2008, 3:22</dc:source>
			<dc:date>2008-09-11</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-22</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>22</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-11</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/21">
            
            <title>Dorsal turning of motor corticospinal axons at the pyramidal decussation requires plexin signaling</title>
			<description>Background:
The development of the corticospinal tract (CST) in higher vertebrates relies on a series of axon guidance decisions along its long projection pathway. Several guidance molecules are known to be involved at various decision points to regulate the projection of CST axons. However, previous analyses of the CST guidance defects in mutant mice lacking these molecules have suggested that there are other molecules involved in CST axon guidance that are yet to be identified. In this study, we investigate the role of plexin signaling in the guidance of motor CST axons in vivo.
Results:
Expression pattern studies show that plexin-A3, plexin-A4, and neuropilin-1 are expressed in the developing cerebral cortex when the motor CST axons originating from layer V cortical neurons are guided down to the spinal cord. By analyzing mutant mice, we show that motor CST axons that turn dorsally to cross the midline at the pyramidal decussation require plexin-A3 and plexin-A4 signaling. Although other CST guidance defects are found in neuropilin-1 mutants, this dorsal turning defect is not observed in either neuropilin-1 or neuropilin-2 mutants, suggesting that the local cues that activate plexin signaling at the dorsal turning point are membrane-bound semaphorins. Further expression pattern study and mutant analysis indicate that Sema6A is one of the local cues for motor CST axon turning at the pyramidal decussation.
Conclusion:
Dorsal turning and midline crossing at the pyramidal decussation is a crucial step to properly direct CST axons into the dorsal spinal cord. We show that the signaling of plexin-A3, plexin-A4, and Sema6A is at least partially required for dorsal turning of the CST axons, while neuropilin-1 is required for proper fasciculation of the tract at midline crossing. Together with previous reports, these results demonstrate that several guidance cues are specifically utilized to regulate the dorsal turning and midline crossing of developing CST axons.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/21</link>
			
			 	<dc:creator>Regina L Faulkner, Lawrence K Low, Xiao-Bo Liu, Jeffrey Coble, Edward G Jones and Hwai-Jong Cheng</dc:creator>
			
			<dc:source>Neural Development 2008, 3:21</dc:source>
			<dc:date>2008-08-26</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-21</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>21</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/20">
            
            <title>Runx transcription factors in neuronal development</title>
			<description>Runt-related (Runx) transcription factors control diverse aspects of embryonic development and are responsible for the pathogenesis of many human diseases. In recent years, the functions of this transcription factor family in the nervous system have just begun to be understood. In dorsal root ganglion neurons, Runx1 and Runx3 play pivotal roles in the development of nociceptive and proprioceptive sensory neurons, respectively. Runx appears to control the transcriptional regulation of neurotrophin receptors, numerous ion channels and neuropeptides. As a consequence, Runx contributes to diverse aspects of the sensory system in higher vertebrates. In this review, we summarize recent progress in determining the role of Runx in neuronal development.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/20</link>
			
			 	<dc:creator>Ken-ichi Inoue, Takashi Shiga and Yoshiaki Ito</dc:creator>
			
			<dc:source>Neural Development 2008, 3:20</dc:source>
			<dc:date>2008-08-26</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-20</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>20</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/19">
            
            <title>The Netrin-related domain of Sfrp1 interacts with Wnt ligands and antagonizes their activity in the anterior neural plate</title>
			<description>Background:
Secreted frizzled related proteins (SFRPs) are multifunctional modulators of Wnt and BMP (Bone Morphogenetic Protein) signalling necessary for the development of most organs and the homeostasis of different adult tissues. SFRPs fold in two independent domains: the cysteine rich domain (SfrpCRD) related to the extracellular portion of Frizzled (Fz, Wnt receptors) and the Netrin module (SfrpNTR) defined by homologies with molecules such as Netrin-1, inhibitors of metalloproteinases and complement proteins. Due to its structural relationship with Fz, it is believed that SfrpCRD interferes with Wnt signalling by binding and sequestering the ligand. In contrast, the functional relevance of the SfrpNTR has been barely addressed.
Results:
Here, we combine biochemical studies, mutational analysis and functional assays in cell culture and medaka-fish embryos to show that the Sfrp1NTR mimics the function of the entire molecule, binds to Wnt8 and antagonizes Wnt canonical signalling. This activity requires intact tertiary structure and is shared by the distantly related Netrin-1NTR. In contrast, the Sfrp1CRD cannot mirror the function of the entire molecule in vivo but interacts with Fz receptors and antagonizes Wnt8-mediated &#946;-catenin transcriptional activity.
Conclusion:
On the basis of these results, we propose that SFRP modulation of Wnt signalling may involve multiple and differential interactions among Wnt, Fz and SFRPs.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/19</link>
			
			 	<dc:creator>Javier Lopez-Rios, Pilar Esteve, Jose Maria Ruiz and Paola Bovolenta</dc:creator>
			
			<dc:source>Neural Development 2008, 3:19</dc:source>
			<dc:date>2008-08-20</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-19</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>19</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-20</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/18">
            
            <title>The Met receptor tyrosine kinase prevents zebrafish primary motoneurons from expressing an incorrect neurotransmitter</title>
			<description>Background:
Expression of correct neurotransmitters is crucial for normal nervous system function. How neurotransmitter expression is regulated is not well-understood; however, previous studies provide evidence that both environmental signals and intrinsic differentiation programs are involved. One environmental signal known to regulate neurotransmitter expression in vertebrate motoneurons is Hepatocyte growth factor, which acts through the Met receptor tyrosine kinase and also affects other aspects of motoneuron differentiation, including axonal extension. Here we test the role of Met in development of motoneurons in embryonic zebrafish.
Results:
We found that met is expressed in all early developing, individually identified primary motoneurons and in at least some later developing secondary motoneurons. We used morpholino antisense oligonucleotides to knock down Met function and found that Met has distinct roles in primary and secondary motoneurons. Most secondary motoneurons were absent from met morpholino-injected embryos, suggesting that Met is required for their formation. We used chemical inhibitors to test several downstream pathways activated by Met and found that secondary motoneuron development may depend on the p38 and/or Akt pathways. In contrast, primary motoneurons were present in met morpholino-injected embryos. However, a significant fraction of them had truncated axons. Surprisingly, some CaPs in met morpholino antisense oligonucleotide (MO)-injected embryos developed a hybrid morphology in which they had both a peripheral axon innervating muscle and an interneuron-like axon within the spinal cord. In addition, in met MO-injected embryos primary motoneurons co-expressed mRNA encoding Choline acetyltransferase, the synthetic enzyme for their normal neurotransmitter, acetylcholine, and mRNA encoding Glutamate decarboxylase 1, the synthetic enzyme for GABA, a neurotransmitter never normally found in these motoneurons, but found in several types of interneurons. Our inhibitor studies suggest that Met function in primary motoneurons may be mediated through the MEK1/2 pathway.
Conclusion:
We provide evidence that Met is necessary for normal development of zebrafish primary and secondary motoneurons. Despite their many similarities, our results show that these two motoneuron subtypes have different requirements for Met function during development, and raise the possibility that Met may act through different intracellular signaling cascades in primary and secondary motoneurons. Surprisingly, although met is not expressed in primary motoneurons until many hours after they have extended axons to and innervated their muscle targets, Met knockdown causes some of these cells to develop a hybrid phenotype in which they co-expressed motoneuron and interneuron neurotransmitters and have both peripheral and central axons.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/18</link>
			
			 	<dc:creator>Alexandra Tallafuss and Judith S Eisen</dc:creator>
			
			<dc:source>Neural Development 2008, 3:18</dc:source>
			<dc:date>2008-07-29</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-18</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>18</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/17">
            
            <title>FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development</title>
			<description>Background:
Growth, differentiation and regional specification of telencephalic domains, such as the cerebral cortex, are regulated by the interplay of secreted proteins produced by patterning centers and signal transduction systems deployed in the surrounding neuroepithelium. Among other signaling molecules, members of the fibroblast growth factor (FGF) family have a prominent role in regulating growth, differentiation and regional specification. In the mouse telencephalon the rostral patterning center expresses members of the Fgf family (Fgf8, Fgf15, Fgf17, Fgf18). FGF8 and FGF17 signaling have major roles in specification and morphogenesis of the rostroventral telencephalon, whereas the functions of FGF15 and FGF18 in the rostral patterning center have not been established.
Results:
Using Fgf15-/- mutant mice, we provide evidence that FGF15 suppresses proliferation, and that it promotes differentiation, expression of CoupTF1 and caudoventral fate; thus, reducing Fgf15 and Fgf8 dosage have opposite effects. Furthermore, we show that FGF15 and FGF8 differentially phosphorylate ERK (p42/44), AKT and S6 in cultures of embryonic cortex. Finally, we show that FGF15 inhibits proliferation in cortical cultures.
Conclusion:
FGF15 and FGF8 have distinct signaling properties, and opposite effects on neocortical patterning and differentiation; FGF15 promotes CoupTF1 expression, represses proliferation and promotes neural differentiation.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/17</link>
			
			 	<dc:creator>Ugo Borello, Inma Cobos, Jason E Long, Cornelis Murre and John LR Rubenstein</dc:creator>
			
			<dc:source>Neural Development 2008, 3:17</dc:source>
			<dc:date>2008-07-14</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-17</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/16">
            
            <title>Identification of genes influencing dendrite morphogenesis in developing peripheral sensory and central motor neurons</title>
			<description>Background:
Developing neurons form dendritic trees with cell type-specific patterns of growth, branching and targeting. Dendrites of Drosophila peripheral sensory neurons have emerged as a premier genetic model, though the molecular mechanisms that underlie and regulate their morphogenesis remain incompletely understood. Still less is known about this process in central neurons and the extent to which central and peripheral dendrites share common organisational principles and molecular features. To address these issues, we have carried out two comparable gain-of-function screens for genes that influence dendrite morphologies in peripheral dendritic arborisation (da) neurons and central RP2 motor neurons.
Results:
We found 35 unique loci that influenced da neuron dendrites, including five previously shown as required for da dendrite patterning. Several phenotypes were class-specific and many resembled those of known mutants, suggesting that genes identified in this study may converge with and extend known molecular pathways for dendrite development in da neurons. The second screen used a novel technique for cell-autonomous gene misexpression in RP2 motor neurons. We found 51 unique loci affecting RP2 dendrite morphology, 84% expressed in the central nervous system. The phenotypic classes from both screens demonstrate that gene misexpression can affect specific aspects of dendritic development, such as growth, branching and targeting. We demonstrate that these processes are genetically separable. Targeting phenotypes were specific to the RP2 screen, and we propose that dendrites in the central nervous system are targeted to territories defined by Cartesian co-ordinates along the antero-posterior and the medio-lateral axes of the central neuropile. Comparisons between the screens suggest that the dendrites of peripheral da and central RP2 neurons are shaped by regulatory programs that only partially overlap. We focused on one common candidate pathway controlled by the ecdysone receptor, and found that it promotes branching and growth of developing da neuron dendrites, but a role in RP2 dendrite development during embryonic and early larval stages was not apparent.
Conclusion:
We identified commonalities (for example, growth and branching) and distinctions (for example, targeting and ecdysone response) in the molecular and organizational framework that underlies dendrite development of peripheral and central neurons.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/16</link>
			
			 	<dc:creator>Yimiao Ou, Barbara Chwalla, Matthias Landgraf and Donald J van Meyel</dc:creator>
			
			<dc:source>Neural Development 2008, 3:16</dc:source>
			<dc:date>2008-07-10</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-16</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>16</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.neuraldevelopment.com/content/3/1/15">
            
            <title>Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1</title>
			<description>Background:
&#946;-Amyloid precursor protein (APP) has been reported to play a role in the outgrowth of neurites from cultured neurons. Both cell-surface APP and its soluble, ectodomain cleavage product (APPs-&#945;) have been implicated in regulating the length and branching of neurites in a variety of assays, but the mechanism by which APP performs this function is not understood.
Results:
Here, we report that APP is required for proper neurite outgrowth in a cell autonomous manner, both in vitro and in vivo. Neurons that lack APP undergo elongation of their longest neurite. Deletion of APLP1 or APLP2, homologues of APP, likewise stimulates neurite lengthening. Intriguingly, wild-type neurons exposed to APPs-&#945;, the principal cleavage product of APP, also undergo neurite elongation. However, APPs-&#945; is unable to stimulate neurite elongation in the absence of cellular APP expression. The outgrowth-enhancing effects of both APPs-&#945; and the deletion of APP are inhibited by blocking antibodies to Integrin &#946;1 (Itg&#946;1). Moreover, full length APP interacts biochemically with Itg&#946;1, and APPs-&#945; can interfere with this binding.
Conclusion:
Our findings indicate that APPs-&#945; regulates the function of APP in neurite outgrowth via the novel mechanism of competing with the binding of APP to Itg&#946;1.</description>
			<link>http://www.neuraldevelopment.com/content/3/1/15</link>
			
			 	<dc:creator>Tracy L Young-Pearse, Allen C Chen, Rui Chang, Cesar Marquez and Dennis J Selkoe</dc:creator>
			
			<dc:source>Neural Development 2008, 3:15</dc:source>
			<dc:date>2008-06-23</dc:date>
			<dc:identifier>doi:10.1186/1749-8104-3-15</dc:identifier>
			
			
							
					<prism:publicationName>Neural Development</prism:publicationName>
					
			
							
					<prism:issn>1749-8104</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-23</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
